Galea, H. , Perry, M. and Jones, P. (2026) Characterising Irritable Bowel Syndrome: An Exploratory Cross-Sectional Study .

BridgeBio Pharma (NASDAQ:BBIO) hosted an investor webinar to outline its clinical and commercial strategy for infigratinib, ...

Natural products industry companies share overviews on the latest science on their dietary supplement branded ingredients and ...